SCHEMBL907336

SCHEMBL907336

CC(C)(C)c1ccc(C(=O)NC(=S)Nc2ccc(N)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 10/20 0.64
ALDH1A1 P00352 3/20 0.62
LMNA P02545 3/20 0.62
MAPT P10636 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
SIRT2 Q8IXJ6 7/20 0.61
SIRT3 Q9NTG7 1/20 0.60
HPGD P15428 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
MEN1 O00255 1/20 0.54
POLB P06746 1/20 0.54
PKM P14618 1/20 0.54
APEX1 P27695 1/20 0.54
KMT2A Q03164 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
HDAC3 O15379 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3400231 0.99 SIRT1 (0.62) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL12067341 0.93 SIRT1 (0.71) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL3850011 0.92 SIRT1 (0.57) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL28662121 0.90 SIRT1 (0.68) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL3400605 0.89 SIRT1 (0.64) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL3400226 0.87 SIRT1 (0.62) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL907582 0.87 SIRT1 (0.65) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL12940302 0.87 SIRT1 (0.65) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL16677197 0.87 MIF (0.66) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL2344788 0.87 KMT2A (0.68) SIRT1ALDH1A1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115724780-B Acylthiourea compound based on hydrophobic tag, preparation method thereof and application of acylthiourea compound in resisting influenza A virus 武汉大学 2024-04-26 CN claimed
CN-112807294-B Application of acyl thiourea compound in preparation of medicines for treating or preventing herpes simplex virus type I infection 武汉大学 2023-09-05 CN claimed
CN-110478344-B Application of acylthiourea compound in preparation of anti-influenza B virus medicine 武汉大学 2022-07-19 CN claimed
CN-113582969-A Application of acylthiourea compound in preparation of anti-enterovirus drugs 武汉大学 2021-11-02 CN claimed
CN-112807294-A Application of acylthiourea compound in preparation of medicine for treating or preventing herpes simplex virus I-type infection 武汉大学 2021-05-18 CN claimed
CN-109096836-B Fluororubber composition 广州弗西林橡塑有限公司 2021-04-06 CN claimed
CN-110483425-A A kind of application of the acyl thiourea compound and preparation method thereof with anti-influenza A virus UNIV WUHAN 2019-11-22 CN claimed
US-20170128393-A1 INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS SIGA TECHNOLOGIES, INC. (US) 2017-05-11 US claimed
EP-2865668-A2 Inhibitors and methods of inhibiting bacterial and viral pathogens Siga Technologies, Inc. (US) 2015-04-29 EP claimed
US-20130195796-A1 Inhibitors and Methods of Inhibiting Bacterial and Viral Pathogens SIGA TECHNOLOGIES INC. (US) 2013-08-01 US claimed
EP-2536286-A1 INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS Siga Technologies, Inc. (US) 2012-12-26 EP claimed
WO-2011103375-A1 INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS SIGA TECHNOLOGIES, INC. (US) 2011-08-25 WO claimed
CN-112807294-B Application of acyl thiourea compound in preparation of medicines for treating or preventing herpes simplex virus type I infection 武汉大学 2023-09-05 CN disclosed
CN-110478344-B Application of acylthiourea compound in preparation of anti-influenza B virus medicine 武汉大学 2022-07-19 CN disclosed
CN-113582969-B Application of acylthiourea compound in preparation of anti-enterovirus drugs 武汉大学 2022-06-14 CN disclosed
CN-113582969-A Application of acylthiourea compound in preparation of anti-enterovirus drugs 武汉大学 2021-11-02 CN disclosed
EP-2099445-B1 P53 ACTIVATING BENZOYL UREA AND BENZOYL THIOUREA COMPOUNDS UNIV DUNDEE (GB) 2010-11-17 EP disclosed
EP-2099445-A2 P53 ACTIVATING BENZOYL UREA AND BENZOYL THIOUREA COMPOUNDS University Court of The University of Dundee (GB) 2009-09-16 EP disclosed
WO-2008029096-A2 P53 ACTIVATING BENZOYL UREA AND BENZOYL THIOUREA COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) 2008-03-13 WO disclosed
WO-2008029096-A2 P53 ACTIVATING BENZOYL UREA AND BENZOYL THIOUREA COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) 2008-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130195796-A1 Inhibitors and Methods of Inhibiting Bacterial and Viral Pathogens TST, TPMT, EIF2AK2 SIRT1 2419/4885ALDH1A1 3069/4885LMNA 4633/4885
US-20170128393-A1 INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS TST, TPMT, EIF2AK2 SIRT1 2419/4885ALDH1A1 3069/4885LMNA 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.